Cargando…

Effect of the Crohn’s Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn’s Disease

(1) Background: The CDED + PEN (partial enteral nutrition) is a promising method of nutritional treatment in active Crohn’s disease (CD). An increase in fecal calprotectin (FCP) level—a marker of mucosal inflammation—happens to be the first evidence of Crohn’s disease exacerbation that appears ahead...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matuszczyk, Małgorzata, Meglicka, Monika, Wiernicka, Anna, Jarzębicka, Dorota, Osiecki, Marcin, Kotkowicz-Szczur, Marta, Kierkuś, Jarosław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317017/ https://www.ncbi.nlm.nih.gov/pubmed/35887910 http://dx.doi.org/10.3390/jcm11144146

Ejemplares similares

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
por: Szymańska, Edyta, et al.
Publicado: (2020)

Oral exclusive enteral nutrition for induction of clinical remission, mucosal healing, and improvement of nutritional status and growth velocity in children with active Crohn’s disease – a prospective multicentre trial
por: Matuszczyk, Małgorzata, et al.
Publicado: (2021)

Dual Biologic Therapy in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Retrospective Study
por: Wlazło, Magdalena, et al.
Publicado: (2022)

Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study
por: Szymanska, Edyta, et al.
Publicado: (2021)

Nutritional Therapy in Pediatric Crohn’s Disease—Are We Going to Change the Guidelines?
por: Matuszczyk, Malgorzata, et al.
Publicado: (2021)

Challenges in Managing Paediatric Crohn’s Disease With Crohn’s Disease Exclusion Diet (CDED): The First Single-Center Study in the United Arab Emirates
por: Alsarhan, Ali, et al.
Publicado: (2023)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Sexual functions in individuals with inflammatory bowel diseases
por: Kotkowicz-Szczur, Marta, et al.
Publicado: (2023)

Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease
por: Kennedy, Nicholas A., et al.
Publicado: (2019)

Inflammatory bowel disease – one entity with many molecular faces
por: Szymańska, Sylwia, et al.
Publicado: (2019)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease
por: Gauss, Annika, et al.
Publicado: (2016)

Can fecal calprotectin better stratify Crohn’s disease activity index?
por: Scaioli, Eleonora, et al.
Publicado: (2015)

Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?
por: Romero-Mascarell, Cristina, et al.
Publicado: (2022)

Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn’s disease
por: Li, Junrong, et al.
Publicado: (2023)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease: Erratum
Publicado: (2016)

Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patients
por: Foster, Alice Jane, et al.
Publicado: (2019)

Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn’s disease
por: Somwaru, Alexander S., et al.
Publicado: (2019)

Fecal Calprotectin for predicting Relapse and Activity in Patients with Crohn’s Disease: A Meta-analysis
por: Zhuge, Ying, et al.
Publicado: (2016)

Optimal Cutoff Level of Fecal Calprotectin for Detecting Small Bowel Inflammation in Crohn’s Disease
por: Kim, Eun Soo
Publicado: (2021)

Fecal Zonulin as a Noninvasive Biomarker of Intestinal Permeability in Pediatric Patients with Inflammatory Bowel Diseases—Correlation with Disease Activity and Fecal Calprotectin
por: Szymanska, Edyta, et al.
Publicado: (2021)

Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis
por: Tham, Yuen Sau, et al.
Publicado: (2018)

Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
por: Paredes, José María, et al.
Publicado: (2022)

Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity
por: Zittan, Eran, et al.
Publicado: (2018)

Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
por: Szczubełek, Martyna, et al.
Publicado: (2021)

Fecal calprotectin in predicting small bowel capsule endoscopy findings in pediatric patients with known Crohn’s disease
por: Wang, Shengnan, et al.
Publicado: (2022)

Clinical Value of Detecting Fecal Calprotectin by Using Colloidal Gold Assay in Screening or Diagnosing Crohn's Disease
por: Zhang, Wangdong, et al.
Publicado: (2023)

Biosimilars in paediatric inflammatory bowel disease
por: Sieczkowska-Golub, Joanna, et al.
Publicado: (2018)

Safety profile of biologic therapy in Polish paediatric patients with Crohn's disease
por: Szymanska, Edyta, et al.
Publicado: (2015)

Extensive Modulation of the Fecal Metagenome in Children With Crohn's Disease During Exclusive Enteral Nutrition
por: Quince, Christopher, et al.
Publicado: (2015)

EEN Yesterday and Today … CDED Today and Tomorrow
por: Herrador-López, Marta, et al.
Publicado: (2020)

Subjective Psychophysical Experiences in the Course of Inflammatory Bowel Disease—A Comparative Analysis Based on the Polish Pediatric Crohn’s and Colitis Cohort (POCOCO)
por: Glapa-Nowak, Aleksandra, et al.
Publicado: (2021)

Increased fecal calprotectin levels in Crohn’s disease correlate with elevated serum Th1- and Th17-associated cytokines
por: Bourgonje, Arno R., et al.
Publicado: (2018)

Fecal calprotectin reflects endoscopic activity in patients with small-bowel Crohn’s disease according to double-balloon endoscopy findings
por: Matsuura, Rinzaburo, et al.
Publicado: (2018)

Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review
por: Simon, Ebby George, et al.
Publicado: (2019)

The risk of cardiovascular complications in inflammatory bowel disease
por: Czubkowski, Piotr, et al.
Publicado: (2020)

Fecal microbiota transplantation for refractory Crohn's disease
por: Bak, Seon Ho, et al.
Publicado: (2017)

Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease
por: Szymanska, Edyta, et al.
Publicado: (2016)

Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin
por: Zubin, Grover, et al.
Publicado: (2015)

Diagnostic Accuracy of Fecal Calprotectin for the Detection of Small Bowel Crohn’s Disease through Capsule Endoscopy: An Updated Meta-Analysis and Systematic Review
por: Jung, Eun Suk, et al.
Publicado: (2021)

Evaluation of Fecal Calprotectin, Serum C-Reactive Protein, Erythrocyte Sedimentation Rate, Seromucoid and Procalcitonin in the Diagnostics and Monitoring of Crohn’s Disease in Children
por: Akutko, Katarzyna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5fjo4d8l1gmsfb723t0eajejpp